Top Tweets for #BenchToBedside
Why choose between bench and bedside? With us, you do both!!
🧪➡️APPLY NOW for PhD program to work in a multidisciplinary environment where fundamental science meets clinical evaluation.
Visit our website for details of our research programs.
#BenchToBedside #HealthResearch
🚨Last date extended till April 30, 2026🚨
Admissions for #AcSIR #PhD (Medical Research)
Join ICMR-NIRWoH (Formerly ICMR-NIRRCH) and work on cutting-edge research in #WomensHealth guided by our top researchers.
Apply here: https://t.co/QxK407qNzH
What an incredible #BenchToBedside Competition Night! 🎉 Thanks to the judges and student leadership team.
Shoutout to the talented student teams who competed, and congratulations to the winning teams for an amazing accomplishment! 👏
https://t.co/S1YGf9kv0K
Honored to attend the Fifth Annual South Florida Translational Research Symposium by FIU: Center for Translational Science.
#CongenitalHeartDisease, #BenchToBedside, plus inspiring work from trainees. Great to reconnect with @DavidKalfaMD and many others. Thank you
Don’t miss #BenchToBedside Competition Night on April 13! 💡
Meet student innovators, explore our new James LeVoy Sorenson Center for Medical Innovation, and celebrate nearly $100K in awards.
Register today: https://t.co/m5QG9jpPQO
Great energy at our Advice from Experts Workshop last week at the new Sorenson Center for Medical Innovation! Huge thanks to the industry pros, student teams, and CMI staff who made it a productive session. 🚀
We can’t wait for B2B Competition Night this April!
#BenchToBedside
GIS 2026 – Day 2 focuses on bridging fundamental discoveries with clinical applications, advancing immunology from bench to bedside.
#GIS2026 #Immunology #BenchToBedside #TranslationalResearch #BRIC #ILS
@DBTIndia | @bric_ils
On the #BenchToBedside podcast, @RoyJensenMD talks with Marilyn Mahan and Karl Frees from our patient research advocacy program, PIVOT. Don't miss this inspiring episode! 🎧 Listen on our website or wherever you find your podcasts ➜ https://t.co/ggYGRAtQ1R
After 20 years away, @RonaldChenMD returned to Kansas to lead innovation and outreach at @KUcancercenter & @KURadonc.
🎧 Hear his story on the #BenchToBedside podcast ➜ https://t.co/zYn1nBSkLH
Opinion piece: How can we improve the efficiency of #BenchToBedside #MedicalAdvances for many major #diseases? #OperationWarpSpeed offers a roadmap. In PNAS Front Matter: https://t.co/9muh9Obaqv
#Alzheimers #PublicHealth #pandemic #COVID19
Opinion piece: How can we improve the efficiency of #BenchToBedside #MedicalAdvances for major #diseases? #OperationWarpSpeed offers a roadmap. In PNAS Front Matter: https://t.co/3NGHmsWXSX
#Alzheimers #PublicHealth #pandemic #COVID19
Opinion piece: #OperationWarpSpeed offers a roadmap for improving the efficiency of #BenchToBedside #MedicalAdvances for numerous major #diseases. In PNAS Front Matter: https://t.co/6710aFlbuS
#Alzheimers #PublicHealth #pandemic #COVID19
A few weeks ago our team, Medhesion pitched and won 1st Place at #StEPIgnite2025 #Biotech #BenchToBedside #Startup #Oxford #HealthcareInnovation
StEP Ignite is a Student Entrepreneurship Programme hosted @enspireoxford @OxUInnovation.
https://t.co/VV4csPvvOO
New season, new stories. 🎧 @RoyJensenMD is back in the studio for the Bench to Bedside podcast, exploring the personal and professional journeys of those who make cancer research and care possible. Coming soon!
#CancerPodcast #BenchToBedside
Fascinating @SmidtHeart research seminar by @FarahSheikhLab of @UCSD on #ARVC— #BenchToBedside journey towards AAV gene therapy with PKP2, now in clinical trials!
🌍 International Summit on Hepatology and Nephrology Research (ISHR-2025); 🔗 Register now and learn more: https://t.co/aN07sAsAbt
#ISHR2025 #HepatologyConference #URFEvents #HepatoRenal #BarcelonaEvents #CME2025 #LiverHealth #KidneyCare #BenchToBedside
🧪 FDA #BenchToBedside video alert!
The @FDAOncology Center of Excellence dives into drug development for rare & economically infeasible cancers — with expert voices from across the agency.
🎥 Watch: https://t.co/uUq2VNa2QL
#Oncology #RareDiseases #DrugDevelopment
🧪 New FDA #BenchToBedside video alert!
The @FDAOncology Center of Excellence dives into drug development for rare & economically infeasible cancers — with expert voices from across the agency.
🎥 Watch: https://t.co/uUq2VNa2QL
#Oncology #RareDiseases #DrugDevelopment
Una nova teràpia CAR-T de #SantPau aconsegueix resultats positius en pacients d’un tipus de #limfoma refractari🔬
🤝🏽Investigadors l’IR Sant Pau, en col·laboració amb l’@HospitalSantPau i l’Institut de Recerca contra la Leucèmia Josep Carreras (@CarrerasIJC), han desenvolupat un tractament innovador de cèl·lules CAR-T dirigit a la proteïna #CD30, que ha demostrat una alta eficàcia en pacients amb limfoma CD30+ refractari.
🧪Ha estat en un assaig clínic de fase I publicat a la prestigiosa revista @BloodJournal. El treball revela que aquest nou CART30 promou l’expansió de cèl·lules T de memòria, fet que es tradueix en respostes duradores i una millor evolució clínica en els pacients tractats.
🚀Les teràpies amb cèl·lules CAR-T han sorgit com una alternativa prometedora en el tractament de neoplàsies hematològiques, aconseguint resultats molt positius en leucèmies i limfomes de cèl·lules B. Tanmateix, la seva aplicació en limfomes CD30+ havia estat limitada a causa de la manca de persistència de les cèl·lules modificades i a la ràpida recaiguda dels pacients.
🌟Gràcies als avenços en enginyeria genètica i biotecnologia, l’equip de l’IR Sant Pau ha aconseguit superar aquestes limitacions i representa una fita en la lluita contra aquests tipus de càncer, obrint noves perspectives per a pacients que fins ara comptaven amb opcions molt reduïdes.
🗣️Segons el Dr. Javier Briones, director del Grup de Recerca en Hematologia Oncològica i Trasplantament de l’IR Sant Pau i director del Servei d’Hematologia de l’Hospital de Sant Pau, investigador principal de l’estudi, «el més sorprenent d’aquest estudi és que la taxa de resposta global va ser del 100 %, quelcom molt poc comú en pacients que han passat per múltiples línies de tractament. A més, el 50 % dels pacients van assolir una remissió completa, la qual cosa significa que la malaltia va desaparèixer completament en els estudis d’imatge i les anàlisis clíniques».
https://t.co/JGPY1PhayP
#JuntsFemRecerca
Muchas felicidades @anita_Caballero!! Por fin en papel el fruto de años y años de esfuerzo de muchísima gente. Seguimos!! @hematosantpau
@HospitalSantPau #benchtobedside #CART #Academy
We are pleased and proud to share with you the results of our Phase 1 academic clinical trial with HSP-CAR30, published in @BloodJournal. It's an honor to contribute to the growing body of research in this exciting field! #CART Read more: https://t.co/XrKTxa15Fz @hematosantpau
Last Seen Hashtags on Sotwe
mama #amigo
Seen from Argentina
ทางบ้านฝากลง
Seen from France
gaypenis
Seen from Turkey
momson()*+*+*+filter:native_video
Seen from Argentina
นัดเย็ดแม่สะเรียง
Seen from Thailand
รับงานระยอง
Seen from Thailand
MOMOCANS
Seen from Indonesia
pizz
Seen from Philippines
Thundr
Seen from Canada
GZSSOX
Seen from United States
Most Popular Users
Elon Musk 
@elonmusk
240.8M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
111.2M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.8M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91M followers
KATY PERRY
@katyperry
87.9M followers
Taylor Swift
@taylorswift13
81.8M followers
Lady Gaga
@ladygaga
73.3M followers
Virat Kohli
@imvkohli
70.4M followers
Kim Kardashian
@kimkardashian
69.9M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.1M followers
Neymar Jr
@neymarjr
63.2M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
61M followers
X
@x
60.8M followers